PHR Phreesia Inc

$20.06

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-10-31
Expected on Dec 08, 2025
Report Time: After the Bell
The Whisper Number
$0.00
Consensus Estimate: $0.00
Revenue Estimate: $120.02M

Latest Earnings Insight

In the upcoming earnings report for Phreesia (PHR), investors will be keenly observing how the company navigates its growth trajectory amidst a challenging market landscape. With a market cap of approximately $1.83 billion, Phreesia stands at a pivotal point where its strategic initiatives to enhance patient intake and engagement solutions could significantly impact its financial performance. The revenue estimate of $116.50 million reflects a cautious optimism, aligning closely with the whisper number, which suggests a neutral stance on earnings per share at $0.00. This alignment indicates that market participants are anticipating steady performance without significant surprises. As Phreesia continues to leverage its technological capabilities to streamline healthcare operations, the focus will be on how these efforts translate into sustained revenue growth and operational efficiency. The forthcoming earnings release will be crucial in assessing whether Phreesia can meet or exceed these tempered expectations and maintain its competitive edge in the healthcare technology sector.

Updated On 11/21/2025

About Phreesia Inc

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.

Website: https://www.phreesia.com

Sector
TRADE & SERVICES
Industry
SERVICES-BUSINESS SERVICES, NEC
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
January
CIK
1412408
Address
434 FAYETTEVILLE ST., SUITE 1400, RALEIGH, NC, US
Valuation
Market Cap
$1.41B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
5.32
Performance
EPS
$-1.02
Dividend Yield
Profit Margin
-13.90%
ROE
-22.70%
Technicals
50D MA
$26.34
200D MA
$23.97
52W High
$30.53
52W Low
$17.07
Fundamentals
Shares Outstanding
59M
Target Price
$31.77
Beta
0.82

PHR EPS Estimates vs Actual

Estimated
Actual

PHR News & Sentiment

Nov 20, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Veeva Systems ( VEEV ) Surpasses Q3 Earnings and Revenue Estimates
Veeva (VEEV) delivered earnings and revenue surprises of +4.62% and +2.44%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 20, 2025 • Zacks Commentary NEUTRAL
After Plunging 18.2% in 4 Weeks, Here's Why the Trend Might Reverse for Phreesia ( PHR )
The heavy selling pressure might have exhausted for Phreesia (PHR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Nov 13, 2025 • Zacks Commentary NEUTRAL
Dare Bioscience, Inc. ( DARE ) Reports Q3 Loss, Lags Revenue Estimates
Dare Bioscience (DARE) delivered earnings and revenue surprises of +15.15% and -95.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 12, 2025 • Zacks Commentary NEUTRAL
KORU Medical Systems, Inc. ( KRMD ) Reports Q3 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of +33.33% and +7.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Oct 27, 2025 • Motley Fool SOMEWHAT-BULLISH
Capricorn Fund Loads Up on Phreesia ( PHR ) With a 484,000 Share Purchase
Capricorn Fund Managers Ltd disclosed a new stake in Phreesia ( NYSE:PHR ) , purchasing 484,500 shares valued at $11.4 million as of September 30, 2025. The transaction, detailed in a Securities and Exchange Commission ( SEC ) filing dated October 17, 2025, marks the fund's initial reportable ...
Sep 05, 2025 • Benzinga SOMEWHAT-BULLISH
Phreesia Analysts Raise Their Forecasts After Q2 Results - Phreesia ( NYSE:PHR )
Phreesia, Inc. PHR posted mixed results for the second quarter on Thursday. The company posted quarterly earnings of 1 cent per share, compared to market estimates of a loss of 6 cents per share. The company's quarterly sales came in at $117.255 million versus expectations of $116.526 million.
Sentiment Snapshot

Average Sentiment Score:

0.244
50 articles with scored sentiment

Overall Sentiment:

Bullish

PHR Reported Earnings

Sep 04, 2025
Jul 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.06
  • Whisper:
  • Surprise %: 116.7%
May 28, 2025
Apr 30, 2025 (Post market)
0.65 Surprise
  • Reported EPS: $0.23
  • Estimate: $-0.42
  • Whisper:
  • Surprise %: 153.8%
Mar 12, 2025
Jan 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $0.18
  • Estimate: $0.11
  • Whisper:
  • Surprise %: 67.1%
Dec 09, 2024
Oct 31, 2024 (Post market)
0.31 Surprise
  • Reported EPS: $0.04
  • Estimate: $-0.27
  • Whisper:
  • Surprise %: 113.6%
Sep 04, 2024
Jul 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.31
  • Estimate: $-0.36
  • Whisper:
  • Surprise %: 13.9%
May 30, 2024
Apr 30, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $-0.35
  • Estimate: $-0.48
  • Whisper:
  • Surprise %: 27.1%
Mar 14, 2024
Jan 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $-0.21
  • Estimate: $-0.26
  • Whisper:
  • Surprise %: 19.2%
Dec 05, 2023
Oct 31, 2023 (Post market)
0.11 Surprise
  • Reported EPS: $-0.25
  • Estimate: $-0.36
  • Whisper:
  • Surprise %: 30.6%
Sep 06, 2023
Jul 31, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $-0.34
  • Estimate: $-0.42
  • Whisper:
  • Surprise %: 19.1%

Financials